Effect of telmisartan and amlodipine on home blood pressure by monitoring newly developed telemedicine system: Monitoring test by using telemedicine. Telmisartan's effect on home blood pressure (TelTelbosu)

Clinical and Experimental Hypertension

Volumn 30, Issue 1, 2008, Pages 57-67

  Nakamoto, Hidetomo ^a   Nishida, Eiichi ^b   Ryuzaki, Munekazu ^c   Sone, Masayoshi ^d   Suzuki, Hiromichi ^a   Yoshimoto, Mitsuo ^e   Itagaki, Kaoru ^e  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

^b Saiseikai Yahata Hospital   (Japan)

^c Department of Nephrology   (Japan)

^d Sone Clinic   (Japan)

^e Clinography Corporation   (Japan)

Author keywords

Cellular telephone; Home blood pressure; Telemedicine

Indexed keywords

AMLODIPINE; TELMISARTAN;

ABSENCE OF SIDE EFFECTS; ADULT; ARTICLE; BLOOD PRESSURE; BLOOD PRESSURE MONITORING; BLOOD PRESSURE VARIABILITY; CIRCADIAN RHYTHM; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; HUMAN; HYPERTENSION; INFORMATION PROCESSING; INFORMATION TECHNOLOGY; INTERNET; MALE; MOBILE PHONE; PULSE RATE; SYSTOLIC BLOOD PRESSURE; TELEMEDICINE;

AMLODIPINE; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; BENZIMIDAZOLES; BENZOATES; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CELLULAR PHONE; FEMALE; HUMANS; HYPERTENSION; INTERNET; MALE; MIDDLE AGED; SELF CARE; TELEMEDICINE; TELEMETRY;

EID: 38549169363     PISSN: 10641963     EISSN: 15256006     Source Type: Journal    
DOI: 10.1080/10641960701815804     Document Type: Article

References (18)

1. Formica M, Quarello F, Stramignoni E, et al. Informatics support and teledialysis. Minerva Urol Nefrol. 1994;46:11-16 (in Italian).
2. Nakamoto H, Kawamoto A, Tanabe Y, Nakagawa Y, Nishida E, Akiba T, Suzuki H. Telemedicine system for CAPD patients by using cellular phone. Adv. Perit. Dial. 2006;19:124-129.
3. Nakamoto H, Hatta M, Tanaka A, Moriwaki K, Oohama K, Kagawa K, Wada K, Suzuki H. Telemedicine system for home automated peritoneal dialysis. Adv. Perit. Dial. 2000;16:191-194.
4. Assaad MAE, Topouchian JA, Asmar RG. Evaluation of two devices for self-measurement of blood reassure according to the international protocol: The Omron M5-I and the Omron 705IT. Blood Pressure Monitoring. 2003;8:127-133.
5. Imai Y, Otsuka K, Kawano Y, Shimada K, Hayashi H, Tochikubo O, Miyakawa M, Fukiyama K, and the Japanese Society of Hypertension. Japanese Society of Hypertension (JSH) guidelines for self-monitoring of blood pressure at home. Hypertens Res. 2003;26:771-782.
6. Imai Y, Hozawa A, Ohkubo T, Tsuji I, Yamaguchi J, Matsubara M, Michimata M, Hashimoto J, Fujiwara T, Nagai K, Kitaoka H, Satoh H, Hisamichi S. Predictive values of automated blood pressure measurement: What can we learn from the Japanese population - the Ohasama study. Blood Press Monit. 2001;6:335-339.
7. Bobrie G, Chatellier G, Genes N, Clerson P, Vaur L, Vaisse B, Menard J, Mallion JM. Cardiovascular prognosis of "masked hypertension" detected by blood pressure self-measurement in elderly treated hypertensive patients. JAMA 2004;291:1342-1349.
8. Chobanian AV, Bakris GL, Black PR, Cushman WC, Green LA, Izzo JL Jr, Jones DW, Materson BJ, Oparil S, Wright JT Jr, Roccella EJ, and the National Heart, Lung, and Blood Institute Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure; National High Blood Pressure Education Program Coordinating Committee. The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The JNC 7 report. JAMA. 2003;289:2560-2572.
9. Whitworth JA, and the World Health Organization, International Society of Hypertension Writing Group. 2003 World Health Organization (WHO)/International Society of Hypertension (ISH) statement on management of hypertension. J Hypertens. 2003;21:1983-1992.
10. European Society of Hypertension - European Society of Cardiology Guidelines Committee. 2003 European Society of Hypertension - European Society of Cardiology guidelines for the management of arterial hypertension. J Hypertens. 2003;21:1011-1053.
11. Saruta T. The Japanese Society of Hypertension guidelines for the management of hypertension (JSH 2004). Nippon Rinsho. 2005;63:952-958 (in Japanese).
12. Haynes RB, Sackett DL, Gibson ES, Taylor DW, Hackett BC, Roberts RS, Johnson AL. Improvement of medication compliance in uncontrolled hypertension. Lancet. 1976;1(7972):1265-1268.
13. O'Brien E, Mee F, Fitzgerald D. The history of blood pressure measurement. J Hum Hypertens. 1994;8:73-84.
14. O'Brien E, Beevers G, Lip GHY. ABC of hypertension, part IV: Automated sphygmomanometry: Self blood pressure measurement. BMJ 2001;322:1167-1170.
15. Imai Y, Poncelet P, DeBuyzere M, Padfield PL, Van Montfrans GA. Prognostic significance of self-measurements of blood pressure. Blood Press Monit. 2000;5:137-143.
16. Imai Y, Nishiyama A, Ohkubo T, Tsuji I, Nagai K, Kikuchi N, Satoh H, Hisamichi S. Factors affecting the nocturnal decrease in blood pressure: A community-based study in Ohasama. J Hypertens. 1997;15:827-838.
17. Suzuki H, Nakamoto H, Okada H, Sugahara S, Kanno Y. Self-measured systolic blood pressure in the morning is a strong indicator of decline of renal function in hypertensive patients with non-diabetic chronic renal insufficiency. Clin Exp Hypertens. 2002;24:249-260.
18. Suzuki H, Kanno Y, Ikeda Y, Nakamoto H, Okada H, Sugahara S. Selection of the dose of angiotensin converting enzyme inhibitor for patients with diabetic nephropathy depends on the presence or absence of left ventricular hypertrophy. Hypertens Res. 2002;25:865-873.